Continuous is not continuous: The incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration

Shigehiko Uchino, Nigel Fealy, Ian Baldwin, Hiroshi Morimatsu, Rinaldo Bellomo

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Objective: There is little information on the duration of time that patients spend off therapy (down-time) during continuous veno-venous haemofiltration (CVVH) and the effect of this treatment free time on azotaemic control. Design and setting: Prospective observational study in the ICU of tertiary hospital. Patients and participants: 48 critically ill patients treated with CVVH at 2 1/h of ultrafiltration. Interventions: Prospective collection of demographic and biochemical data. Measurements and results: Two hundred and sixty-six filters were observed. Start and end times were collected for each filter. Creatinine and urea were measured daily and percentage of reduction of these two solutes was calculated (%Δ creatinine and urea). The median period when CVVH was not applied to a patient (down-time) was 3 h per day. There was a significant inverse correlation between down-time and %Δ creatinine and urea over each 24-h time cycle. On average at least 16 h per day of CVVH was required to maintain creatinine and urea concentration for each 24-h cycle. Conclusions: "Continuous" therapy is not truly continuous. Down-time adversely affects azotaemic control. Physicians prescribing CRRT should be aware of the consequences of such down-time on the quality and quantity of renal replacement therapy delivered.

Original languageEnglish
Pages (from-to)575-578
Number of pages4
JournalIntensive Care Medicine
Volume29
Issue number4
Publication statusPublished - Apr 1 2003
Externally publishedYes

Fingerprint

Hemofiltration
Incidence
Urea
Creatinine
Renal Replacement Therapy
Ultrafiltration
Tertiary Care Centers
Critical Illness
Observational Studies
Therapeutics
Demography
Prospective Studies
Physicians

Keywords

  • Acute kidney failure
  • Critical illness
  • Haemofiltration
  • Renal replacement therapy

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Continuous is not continuous : The incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. / Uchino, Shigehiko; Fealy, Nigel; Baldwin, Ian; Morimatsu, Hiroshi; Bellomo, Rinaldo.

In: Intensive Care Medicine, Vol. 29, No. 4, 01.04.2003, p. 575-578.

Research output: Contribution to journalArticle

@article{74433698c22e4e7591c99f185c6b2441,
title = "Continuous is not continuous: The incidence and impact of circuit {"}down-time{"} on uraemic control during continuous veno-venous haemofiltration",
abstract = "Objective: There is little information on the duration of time that patients spend off therapy (down-time) during continuous veno-venous haemofiltration (CVVH) and the effect of this treatment free time on azotaemic control. Design and setting: Prospective observational study in the ICU of tertiary hospital. Patients and participants: 48 critically ill patients treated with CVVH at 2 1/h of ultrafiltration. Interventions: Prospective collection of demographic and biochemical data. Measurements and results: Two hundred and sixty-six filters were observed. Start and end times were collected for each filter. Creatinine and urea were measured daily and percentage of reduction of these two solutes was calculated ({\%}Δ creatinine and urea). The median period when CVVH was not applied to a patient (down-time) was 3 h per day. There was a significant inverse correlation between down-time and {\%}Δ creatinine and urea over each 24-h time cycle. On average at least 16 h per day of CVVH was required to maintain creatinine and urea concentration for each 24-h cycle. Conclusions: {"}Continuous{"} therapy is not truly continuous. Down-time adversely affects azotaemic control. Physicians prescribing CRRT should be aware of the consequences of such down-time on the quality and quantity of renal replacement therapy delivered.",
keywords = "Acute kidney failure, Critical illness, Haemofiltration, Renal replacement therapy",
author = "Shigehiko Uchino and Nigel Fealy and Ian Baldwin and Hiroshi Morimatsu and Rinaldo Bellomo",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "29",
pages = "575--578",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Continuous is not continuous

T2 - The incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration

AU - Uchino, Shigehiko

AU - Fealy, Nigel

AU - Baldwin, Ian

AU - Morimatsu, Hiroshi

AU - Bellomo, Rinaldo

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objective: There is little information on the duration of time that patients spend off therapy (down-time) during continuous veno-venous haemofiltration (CVVH) and the effect of this treatment free time on azotaemic control. Design and setting: Prospective observational study in the ICU of tertiary hospital. Patients and participants: 48 critically ill patients treated with CVVH at 2 1/h of ultrafiltration. Interventions: Prospective collection of demographic and biochemical data. Measurements and results: Two hundred and sixty-six filters were observed. Start and end times were collected for each filter. Creatinine and urea were measured daily and percentage of reduction of these two solutes was calculated (%Δ creatinine and urea). The median period when CVVH was not applied to a patient (down-time) was 3 h per day. There was a significant inverse correlation between down-time and %Δ creatinine and urea over each 24-h time cycle. On average at least 16 h per day of CVVH was required to maintain creatinine and urea concentration for each 24-h cycle. Conclusions: "Continuous" therapy is not truly continuous. Down-time adversely affects azotaemic control. Physicians prescribing CRRT should be aware of the consequences of such down-time on the quality and quantity of renal replacement therapy delivered.

AB - Objective: There is little information on the duration of time that patients spend off therapy (down-time) during continuous veno-venous haemofiltration (CVVH) and the effect of this treatment free time on azotaemic control. Design and setting: Prospective observational study in the ICU of tertiary hospital. Patients and participants: 48 critically ill patients treated with CVVH at 2 1/h of ultrafiltration. Interventions: Prospective collection of demographic and biochemical data. Measurements and results: Two hundred and sixty-six filters were observed. Start and end times were collected for each filter. Creatinine and urea were measured daily and percentage of reduction of these two solutes was calculated (%Δ creatinine and urea). The median period when CVVH was not applied to a patient (down-time) was 3 h per day. There was a significant inverse correlation between down-time and %Δ creatinine and urea over each 24-h time cycle. On average at least 16 h per day of CVVH was required to maintain creatinine and urea concentration for each 24-h cycle. Conclusions: "Continuous" therapy is not truly continuous. Down-time adversely affects azotaemic control. Physicians prescribing CRRT should be aware of the consequences of such down-time on the quality and quantity of renal replacement therapy delivered.

KW - Acute kidney failure

KW - Critical illness

KW - Haemofiltration

KW - Renal replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=0037396846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037396846&partnerID=8YFLogxK

M3 - Article

C2 - 12577144

AN - SCOPUS:0037396846

VL - 29

SP - 575

EP - 578

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 4

ER -